Table 2. Blood cell count and FN.
| CLB-1996 No. of | FN | Elypse 1 No. of | FN | Elypse 0 No. of | FN | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| patients (%) | N | (%) | χ2 P | patients (%) | N | (%) | χ2 P | patients (%)a | N | (%) | χ2 P | |
| Day 1 lymphocyte count | 0.05 | 0.18 | 0.08 | |||||||||
| ⩽700 μl−1 | 204 (22) | 27 | (14) | 36 (11) | 4 | (11) | 227 (82) | 48 | (21) | |||
| >700 μl−1 | 746 (78) | 65 | (8) | 277 (89) | 16 | (6) | 49 (18) | 16 | (33) | |||
| Day 5 lymphocyte count | NA | 0.004 | <0.001 | |||||||||
| ⩽700 μl−1 | NA | NA | 57 (21) | 9 | (16) | 146 (44) | 71 | (49) | ||||
| >700 μl−1 | NA | NA | 253 (79) | 11 | (4) | 183 (56) | 19 | (10) | ||||
| Day 1 PMN count | 0.41 | 0.67 | 0.16 | |||||||||
| ⩽1500 μl−1 | 19 (2) | 2 | (9) | 18 (8) | 1 | (6) | 23 (8) | 8 | (35) | |||
| >1500 μl−1 | 931 (98) | 90 | (9) | 295 (92) | 19 | (6) | 253 (92) | 56 | (22) | |||
| Day 5 PMN count | NA | 0.45 | 0.07 | |||||||||
| ⩽1500 μl−1 | NA | NA | 9 (3) | 1 | (5) | 16 (5) | 7 | (44) | ||||
| >1500 μl−1 | NA | NA | 301 (97) | 19 | (6) | 257 (95) | 59 | (23) | ||||
| Day 1 platelet count | 0.13 | 0.61 | <0.001 | |||||||||
| <150 000 μl−1 | 89 (9) | 13 | (14) | 14 (5) | 1 | (7) | 23 (9) | 17 | (71) | |||
| >150 000 μl−1 | 861 (91) | 79 | (9) | 299 (95) | 19 | (6) | 253 (91) | 47 | (19) | |||
| Day 1 haemoglobin count | 0.22 | 0.10 | 0.04 | |||||||||
| <12 g dl−1 | 448 (47) | 49 | (11) | 161 (51) | 7 | (4) | 160 (58) | 44 | (27) | |||
| >12 g dl−1 | 502 (53) | 43 | (9) | 154 (49) | 13 | (8) | 117 (42) | 20 | (17) |
a
Missing data in 56 patients. FN=febrile neutropenia, NA=not available. P value refers to χ2 test for association between risk factor and FN.